SEC Form 4 · accession 0001225208-16-032511
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donna James
Director
Period of report
May 3, 2016
Accepted (ET)
May 4, 2016 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Stock UnitsF2,F1,F3 | — | May 3, 2016 | A | 8,494 | A | — | — | Common Stock | 8,494 | 8,494 | D |
Explanation of responses
- F1Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- F2Reflects a value of $185,000 divided by the closing price of common stock on the date of grant.
- F3Annual equity award in the form of deferred stock units vesting in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan.